CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q1 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $34,193,000 | +148.9% | 661,883 | +19.4% | 0.03% | +170.0% |
| Q2 2022 | $13,735,000 | +79.7% | 554,300 | +81.8% | 0.01% | +100.0% |
| Q1 2022 | $7,643,000 | -27.6% | 304,866 | +5.2% | 0.01% | -16.7% |
| Q4 2021 | $10,556,000 | +4391.9% | 289,902 | +2008.4% | 0.01% | – |
| Q3 2021 | $235,000 | +9.8% | 13,750 | -13.9% | 0.00% | – |
| Q2 2021 | $214,000 | -83.9% | 15,977 | -38.3% | 0.00% | -100.0% |
| Q1 2021 | $1,326,000 | -20.0% | 25,882 | -3.4% | 0.00% | 0.0% |
| Q4 2020 | $1,658,000 | +52.5% | 26,785 | +35.0% | 0.00% | 0.0% |
| Q3 2020 | $1,087,000 | -5.4% | 19,843 | -0.6% | 0.00% | 0.0% |
| Q2 2020 | $1,149,000 | +101.2% | 19,963 | +40.4% | 0.00% | 0.0% |
| Q1 2020 | $571,000 | +5.0% | 14,223 | +3.4% | 0.00% | – |
| Q4 2019 | $544,000 | +724.2% | 13,755 | +16.4% | 0.00% | – |
| Q3 2013 | $66,000 | – | 11,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |